Vascular dysfunction in hypertensive condition is characterized by impaired endothelial function and reduced artery elasticity. Circulating endothelial microparticles (EMPs) and brachial-ankle pulse wave velocity (baPWV) are novel evaluation parameters for vascular function. However, their changes in patients with well-controlled blood pressure (BP) have not been fully acquired. To address this issue, circulating EMPs, defined as CD31 þ /CD42À MPs and baPWV were detected in 30 healthy subjects, 30 uncontrolled hypertensive (UCHT) patients and 23 well-controlled hypertensive (WCHT) patients. UCHT patients displayed elevated baPWV (Po0.01) and circulating EMPs (Po0.01) compared with healthy subjects. In WCHT patients, vascular damage represented by these two parameters constantly existed (Po0.01). Values of circulating EMPs were positively related to baPWV (Po0.01). Multivariate regression defined circulating EMPs as an independent contributor to the increase of baPWV value (Po0.05). Our study indicated that though BP was controlled, impaired endothelial function and arterial elasticity continued. The optimal therapy for patients with hypertension should include not only lowering BP but also improvement of vascular injury in parallel.
Introduction
Hypertension is a powerful risk factor for the incidence of vascular disease. In clinical practice, brachial blood pressure (BP) is employed as the major criterion for the diagnosis of hypertension and efficacy of blood pressure-lowering therapy. 1 Although antihypertensive pharmacotherapy with the specific and arbitrary goal to modify BP profiles significantly reduced vascular events, emerging evidence indicates that with equivalent effects on lowering blood pressure, some but not all antihypertensive agents, lead to more reduction of vascular events. 2, 3 This apparently beneficial effects beyond BP lowering may be, at least in part, because of further improvement of agent-related vascular properties, [2] [3] [4] [5] [6] suggesting that the evaluation of vascular function may be useful complement to brachial BP levels, and may provide more sensitive and specific markers for the vascular risk stratification. Impaired endothelial function and reduced arterial elasticity are the hallmarks of hypertensive vascular injury and potent independent predictors of future vascular events. 1, [7] [8] [9] [10] We and others showed that endothelial function is involved in the regulation of arterial elasticity. [11] [12] [13] [14] Our previous study, using brachial-ankle pulse wave velocity (baPWV) for artery elasticity and circulating endothelial microparticles (EMPs, defined as CD31 þ /CD42À MPs) for endothelial function assessment showed that the level of circulating EMPs was highly closed to baPWV in well-functional healthy subjects. 15 baPWV has been testified to be the alternative of aortic PWV and shown to be a better marker for the clinical evaluation of vascular abnormality. 16, 17 Circulating EMPs emerged as the sensitive marker of endothelial perturbation in response to adverse stimuli. 18 It has been reported that in patients with hypertension, increased EMPs and reduced artery elasticity are present.
EMPs and baPWV levels in patients with controlled BP. In this study, we conducted a cross-sectional study to investigate the alteration of circulating CD31 þ /CD42À MPs and its relation to baPWV in well-controlled hypertensive (WCHT) patients and uncontrolled hypertensive (UCHT) patients compared with age-and gender-matched healthy subjects.
Materials and methods

Study subjects
The cross-sectional study population consisted of 83 subjects-30 healthy subjects, 30 patients with UCHT and 23 patients with WCHT. Their demographic and clinical data are shown in Table 1 . The inclusion criterion was age 45-70 years. Exclusion criteria were marked hypercholesterolaemia (total cholesterolX6.2 mM), heavy smoking habit (X10ci-garettes per day), alcohol abuse (X80 g per day), diabetes mellitus, cardiac or cerebral ischaemic vascular diseases, impaired renal function and other major or acute pathologies. Secondary forms of hypertension were excluded by routine diagnostic procedures. Hypertensive subjects were characterized by a supine arterial BP (after 10 min of rest) either consistently X140/90 mm Hg (UCHT group) or o140/90 mm Hg (WCHT group) as measured by mercury sphygmomanometer three times at 1-week intervals. WCHT patients were lasting for at least 3 months. All hypertensive patients had received antihypertensive treatment with calcium channel blockers, angiotensin converting enzyme inhibitor, diuretics or b-blockers as shown in Table 1 . There was no statistically significant difference in the therapeutic regimens of the two groups. The genderand age-matched normotensive healthy subjects had no history of treatment with antihypertensive drugs or on any medications. The protocol was approved by institutional guidelines of the Ethics Committee of the First Affiliated Hospital of Sun Yat-Sen University. All subjects were aware of the investigational nature of the study and gave their written consents.
Laboratory and bioanalytical procedures
Routine laboratory tests including serum total cholesterol, total triglyceride, low-density lipoprotein-cholesterol, high-density lipoprotein-cholesterol and fasting plasma glucose were determined by the standard laboratory methods.
Assessment of baPWV
Brachial-ankle pulse wave velocity was measured using a volume-plethymographic apparatus (VP-2000; Colin, Japan). This instrument records PWV, blood pressure, electrocardiogram and heart sounds simultaneously. 21 Participants were rested in the supine position for at least 15 min. Pneumatic pressure cuffs were placed snugly around both arms and both ankles. Electrocardiographic electrodes were attached on both wrists, and a microphone for phonocardiography was placed at the second intercostals space at the left margin of the sternum to capture heartbeats. After completion of the preparation, the fully automatic data acquisition and processing procedure started with the simultaneous measurements of BP over the four extremities by oscillometric principle, followed by performing the pulse volume waveform recording over right arm and both ankles for 10 s, when the cuff pressures were maintained at the level of 60 mm Hg. The recorded cuff pressure signals during pulse volume recording are known as the pulse volume traces that have been found to correspond to the intra-arterial pressure contours. 22 The simultaneously recorded pulse volume traces were processed instantaneously to provide the pulse transit time (foot-to-foot intervals) between right arm and right ankle, and between left arm and left ankle, respectively. The assumed pulse travel distance between the arm and ankle was calculated automatically from height according to the regression equationdistance ¼ 0.5934 Â height þ 14.401. 21 Thereafter, the right brachial-to-right ankle PWV was calculated automatically as distance/transit time between right arm and right ankle, and left brachial-to-left ankle PWV as distance/transit time between left arm and left ankle. The intraobserver repeatability coefficient of baPWV was 0.91. The baPWV was expressed as cm s À1 .
CD31 þ /CD42À MPs isolation and immunolabelling
Circulating CD31 þ /CD42À MPs were isolated from 4 ml of venous citrated blood drawn from forearm as described previously. 15 Briefly, the platelet-free plasma was separated from the 4 ml blood sample by centrifugation at 160 Â g(10 min), and then by 1000 Â g(6 min). In all, 50 ml of plasma was incubated with anti-CD31-PE(5 ml per test) and , and e were from healthy subject, UCHT patients and WCHT patients, respectively. EMPs, endothelial microparticles; MPs, microparticles; UCHT, uncontrolled hypertensive; WCHT, well-controlled hypertensive.
anti-CD42b-FITC (5 ml per test) antibodies or their respective isotypic immunoglobulins (all from Colcoulter, Beckman Coulter, Immunotech, Marseille, France) at room temperature for 30 min at dark with regular shaking.
Flow cytometric analysis
Samples were analysed on an EPICS Altra (Beckman Coulter, Calif, USA) as described previously by an independent examiner who was unaware of the subject status. The 1 mm diametre beads (Colcoulter, Beckman Coulter), which was run separately before samples each time, were used to define the upper limit of gate A, (Figure 1a ). The lower limit of gate A was defined according to the borderline of the majority of events. When running samples, after using isotypic control to exclude non-specific fluorescence, events with a 0.1 to 1 mm diameter (gate A) were identified in forward scatter and side scatter intensity dot representation using gated MPs. The events were then plotted on one-or two-colour fluorescence histograms. MPs of endothelial origin were defined as elements that had a size o1 mm and 40.1 mm, positively labelled as anti-CD31À PE and negatively labelled as anti-CD42bÀ FITC (CD31 þ /CD42bÀ MPs). The absolute concentration of circulating CD31 þ /CD42À MPs was calculated using the 10-mm flowcount calibrator beads with known concentration provided by the manufacturer (Colcoulter, Beckman Coulter, France), which was added (50 ml per test) into the sample right before flow cytoanalysis. The representative graphs were shown in Figures 1c, d and e. The final number of CD31 þ /CD42À MPs was expressed as MPs per ml. 
Statistical analysis
Results
Clinical characteristics of the study subjects The general characteristics of the three groups are presented in Table 1 . Age, gender, body mass index, current smoking, heart rate, lipid profiles and fasting glucose were similar among the three groups. The serum high-sensitive C-reactive protein (hsCRP) level did not differ significantly between WCHT and UCHT patients, but it was significantly higher in hypertensive patients than in healthy subjects (Po0.05). Systolic BP, diastolic BP and pulse pressure were significantly higher in UCHT patients than in either WCHT patients or healthy subjects (Po0.05), whereas there was no difference between the latter two groups (P ¼ not significant).
Analysis of values of baPWV and circulating CD31 þ /CD42À MPs Values of baPWV and circulating CD31 þ /CD42À MP levels were included in Table 1 . They were significantly higher in UCHT patientsthan in healthy subjects (Figure 2 ). These two parameters were lower in patients with WCHT than in patients with UCHT, but still significantly higher than in healthy subjects ( Figure 2) . In all the subjects studied in this cross-sectional study, values of baPWV were robustly related to age and BP levels (Table 2a and Figure 2 ). Circulating CD31 þ /CD42À MPs were positively correlated with BP levels and values of baPWV (Table 2a) . Furthermore, the partial correlation for age and BP levels between them was 0.511 (Po0.0001). In multivariable analysis in which baPWV was taken as a dependent variable and age, mean BP, body mass index, lipids and other confounders, including circulating CD31 þ /CD42À MPs, were taken as independent variables, we found that apart from age and BP levels, which are two determinants of arterial elasticity, circulating CD31 þ /CD42À MPs were the only predictor stayed in the regression model (R 2 ¼ 0.646, F ¼ 53.24, Po0.0001). In combined groups, including healthy subjects and patients with WCHT, the relationship between circulating CD31 þ /CD42À MPs and BP levels did not exist. However, CD31 þ /CD42À MPs were still positively correlated with values of baPWV (Table 2b and Figure 3 ).
Discussion
The major findings of this study are that high levels of baPWV and circulating EMPs were still present in WCHT patients compared with healthy subjects. Value of baPWV was robustly associated with number of circulating EMPs in all the studied subjects, and multivariate regression defined circulating EMPs as an independent contributor to the increase of baPWV value. Our study showed that though BP is controlled, hypertensive patients still have persistent vascular damage. Hypertensive vascular function measurement may provide more information on vascular injury and risk stratification, which is helpful in making therapeutic strategy aimed at reduction in vascular events.
Circulating EMPs and baPWV are sensitive and convenient measurements that are newly adapted for the clinical evaluation of endothelial function and arterial elasticity in a number of selected patients with cardiovascular disorders. [23] [24] [25] Detections of circulating EMPs and baPWV are interesting and valuable tools to appreciate the ongoing and progression of hypertensive patients as well. Hypertension is accompanied by the reduced arterial elasticity and impaired endothelial function, which synergistically contribute to the pathogenesis of vascular disease. 1, 6, 9, 19 In our study, hypertensive patients displayed both elevated levels of circulating EMPs and faster baPWV, which was consistent with the earlier studies. 19, 20 Therefore, it is believed that antihypertensive treatment for patients with hypertension should restore the vascular dysfunction. In our study, WCHT patients did show reduced levels of circulating EMPs and slower baPWV to some extent, indicating that pressure-lowering therapy is critical in improving vascular function.
The most important aim of this study was to investigate whether the effect of elevated BP alone accounts for increased baPWV and CD31 þ /CD42À MPs, and we also studied the influence of normalized BP on these two parameters. In our studies, we found that baPWV was significantly faster, and circulating CD31 þ /CD42À MPs were elevated in patients with uncontrolled BP compared with healthy subjects, which is in line with the earlier reports. 15, 26 Unexpectedly, WCHT patients recruited in our study who have normal BP levels still displayed faster baPWV and higher CD31 þ /CD42À MPs compared with healthy subjects, indicating that patients with hypertension display profound vascular dysfunction. Brachial BP levels may not be sufficient as the only parameters that employed in the evaluation of vascular risks, efficacy of pressurelowering therapy and prognosis of hypertensive patients. Measurement of vascular function may provide equal, if not more, valuable instructions in clinical practice. On the basis of the current observation, it is reasonable that dysfunctional endothelium with subsequently diminished artery elasticity synergistically facilitates development of vascular abnormalities injury in patients with hypertension. This notion is further supported by recent European guideline of hypertensive treatment in which the arterial stiffness evaluation should be routinely performed in patients with hypertension. In this study, we also found a robust relationship between the values of baPWV and circulating EMPs in all subjects even when age and BP levels were corrected. In combined group, including healthy subjects and patients with WCHT, whose BP levels were within normal range, the association was still significant. Multivariate analysis, age, systolic BP, EMPs, total cholesterol (TC), triglyceride (TG), fasting plasma glucose (FPG), CRP as independent variables indicated that circulating EMPs were the only variable that involved in the regression model in addition to the age and BP levels. It further supported that, no matter in healthy subjects or in hypertensive patients, the association between arterial elasticity and endothelial function profoundly exists. Although our cross-sectional study was unable to infer the causal relationship between the two parameters, a handful in vitro and in vivo evidence has shown that endothelium is capable of regulating the changes of vascular components including smooth muscle cells and extracellular matrix. [28] [29] [30] In this regard, we believe that artery elasticity is more likely to be the comprehensive outcome of various statuses in which endothelial function may play a pivotal role.
The exact mechanisms of circulating EMP elevation in hypertensive patients are not completely clear and beyond the scope of this study. It can be postulated as follows. One is because of high BP as shown by the present data and earlier report. 20 The other one may be related to inflammatory stimulation on vascular endothelium. Similar to the earlier investigations, 31, 32 this study showed that the patients with hypertension had increased CRP, which is a marker for the presence of inflammation. Recently, we found that that CRP is able to induce EMP production in human umbilical vein endothelial cells (HUVECs). 33 Therefore, it can be postulated that the high level of plasma CRP may lead to circulating EMP elevation in patients with hypertension. However in this study, we did not find significant relationship between CRP and EMPs. This is probably because of the heterogeneous nature of the studied subjects and medications in hypertensive patients. EMPs are not only the index of endothelial dysfunction but also the detrimental mediator to contribute to the progression of endothelial perturbation by multiple mechanisms. 18, 34 The in vivo relationship between CRP and EMPs needs to be further addressed.
This study has important clinical implications. Patients with essential hypertension are prone to suffering from vascular diseases. The mechanisms other than elevated BP, including endothelial dysfunction and arterial stiffness, are both involved in the pathogenesis of vascular disease. 7, 35 Earlier, we have found that impaired endothelial function is associated with increased arterial stiffness. 13, 14 Large artery stiffness causes a premature return of reflected waves in late systole, leading to increase in central pulse pressure, and thus systolic BP and load on the ventricle and oxygen demand. 8 The data reported here showed that WCHT patients exhibited presence of increased circulating CD31 þ / CD42À MPs and fast baPWV, suggesting that the improvement in endothelial function and arterial elasticity is a novel therapeutic target to further reduce the risk of cardiovascular disease for patients with hypertension after normalizing BP. It is potential that the beneficial effects on vascular homoestasis can occur with or without a fall in cuff BP of the brachial artery and may explain the pressure-independent effects of some drugs, such as angiotensin converting enzyme inhibitor (ACEI), angiotensin receptor blocker (ARB) and calcium channel blocker (CCB). [2] [3] [4] [5] 36 Therefore, optimal treatment of high BP should include evaluation of arterial elasticity, augmentation index of aortic pressure and left ventricular wasted energy, all of which should be reduced to the lowest level.
There are some limitations to this study. First, its comparatively small sample size and its cross-sectional nature limit its ability to infer causal relations among variables. Large prospective investigations and in vitro experiments would be required to confirm whether EMPs affect vascular function, and its underlying mechanisms remain to be further elucidated. Second, in this study patients with WCHT displayed elevated EMP levels and fast baPWV after, at least in part, 3 months of antihypertensive treatment. Whether the prolonged antihypertensive therapy leads to further improvement of vascular function remained to be studied. Third, CD31 þ / CD42À MPs, though has been well ruled out the platelet MPs, which take large part of circulating MPs, may also include CD31 þ MPs of leukocyte origin. However, in Pirro's report, 37 a negligible number of leukocyte (CD31 þ /CD45 þ ) MPs contaminating the whole CD31 þ MPs population (o5%) might have lessened this limit. Finally, we used baPWV, the surrogate marker of aortic PWV to evaluate the large artery elasticity, because baPWV has been proved closely related to aortic PWV and has been used as a well-accepted surrogate end point predicting cardiovascular events in earlier studies. 16, 17, 38 However, large sample and prospective studies will still be needed to further confirm its usefulness in clinical practice. Further investigation is now being performed in our laboratory to answer this question.
In conclusion, this study indicated that WCHT patients exhibit profound vascular dysfunction manifested by elevated circulating EMPs and faster baPWV. Impaired endothelial function is related to reduced artery elasticity. Artery elasticity and endothelial function assessment may be useful complement to brachial BP levels, when evaluating the vascular risk stratification beyond the traditional application of associated risk factors in patients with hypertension. The optimal therapy for patients with hypertension should include not only lowering BP but also reversal of vascular wall injury in parallel.
What is known about the topic K Vascular dysfunction in hypertensive condition is characterized by impaired endothelial function and reduced artery elasticity. K Circulating endothelial microparticles (EMPs) and brachial-ankle pulse wave velocity (baPWV) are novel evaluation parameters for vascular function. K There are no data to show the effects of blood pressure lowering on both circulating EMPs and baPWV in wellcontrolled hypertensive patients.
What this study adds K Well-controlled hypertensive patients still have faster baPWV and higher circulating EMPs compared with healthy subjects. K Impaired endothelial function is associated with reduced arterial elasticity. K The optimal therapy for patients with hypertension should include not only lowering BP but also reversal of vascular wall injury in parallel.
